JJJiadong Jin

Jiadong Jin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiadong Jin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Jiangbo Hua

    Collaborative Innovation Center of Advanced Microstructures, Jiangsu Provincial Key Laboratory of Photonic and Electronic Materials, School of Electronic Science and Engineering, Nanjing University, Nanjing 210093, China

    1 shared publication
  • Lijia Pan

    Collaborative Innovation Center of Advanced Microstructures, School of Electronic Science and Engineering Nanjing University Nanjing China

    1 shared publication
  • Wen Cheng

    School of Integrated Circuits Nanjing University Suzhou China

    1 shared publication
  • Wenkai Zhu

    Collaborative Innovation Center of Advanced Microstructures, Jiangsu Provincial Key Laboratory of Photonic and Electronic Materials, School of Electronic Science and Engineering, Nanjing University, Nanjing 210093, China

    1 shared publication
  • Yi Shi

    Nanjing University

    1 shared publication
  • Yongchang Jiang

    Collaborative Innovation Center of Advanced Microstructures, Jiangsu Provincial Key Laboratory of Photonic and Electronic Materials, School of Electronic Science and Engineering, Nanjing University, Nanjing 210093, China

    1 shared publication

Latest Publications

  • Open Access

    AI-Enabled Flexible Sensing Ecosystems for Parkinson’s Disease: Advancing Digital Biomarkers and Closed-Loop Interventions

    by Jiadong Jin, Yongchang Jiang, Yukai Zhou, Wenkai Zhu, Jiangbo Hua, Wen Cheng, Yi Shi, Lijia Pan

    Effective Parkinson’s disease (PD) management is hindered by the intermittent nature of clinical snapshots and the discomfort of rigid monitoring hardware. This review critically evaluates the synergy between flexible bioelectronics and artificial intelligence (AI) for continuous remote monitoring. Our analysis reveals that while material innovations have achieved milligram-level sensitivity, a significant ‘translational gap’ persists due to limited validation in real-world environments and small cohort sizes. We conclude that multimodal fusion architectures are essential for accurately mapping digital biomarkers to clinical gold standards such as MDS-UPDRS. By leveraging edge AI for privacy and closed-loop feedback for intervention, this integration facilitates the transition from reactive clinical visits to proactive, personalized digital home-care ecosystems.